The Vita Coco Company Inc vs Merck & Co., Inc. — how do they compare? The Vita Coco Company Inc trades at $74.45 (market cap $4.26B), while Merck & Co., Inc. trades at $122.03 (market cap $306.33B). The key difference: Merck & Co., Inc. is far larger — about 71.9× The Vita Coco Company Inc's market cap, and Merck & Co., Inc. pays a 2.74% dividend while The Vita Coco Company Inc pays none. Which is the better fit depends on your goals.
| COCO | MRK | |
|---|---|---|
Market Cap | $4.26B | $306.33B |
Sector | Technology | Health |
52-Week High | $84.02 | $129.52 |
52-Week Low | $32.30 | $77.60 |
Enterprise Value | $4.07B | $349.75B |
Dividend Yield | — | 2.74% |
Trailing returns across standard periods
Latest headlines on both assets
The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.
Read more on COCO →Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →